Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial.
- 2024-05-18
- RCT · n = 70
- European journal of nutrition 63(6)
- Neda Dolatkhah
- Alireza Jafari
- Fariba Eslamian
- Vahideh Toopchizadeh
- Parviz Saleh
- Maryam Hashemian
- PubMed: 38761281
- DOI: 10.1007/s00394-024-03428-5
- High evidence
- Rigorous Journal
- Clinical
probiotic was better than placebo in decreasing the pain intensity measured by visual analogue scale (VAS) [-2.11 (-2.59, -1.62) in probiotic group and -0.90 (-1.32, -0.48) in placebo group, p = 0.002]
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- not specified